Brought to you by 
Tripos designs and synthesizes compounds for Pfizer
17 Apr 2006
Executive Summary
Tripos (discovery software and research services) will use its software and expertise to design, synthesize, and purify an undisclosed number of compounds to expand Pfizer's library.
Deal Industry
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
- Molecular Diversity
-
Drug Discovery Tools
Deal Status
- Concluded
Deal Type
-
Alliance
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Tripos designs and synthesizes compounds for Pfizer
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice